AmexDrug Corporation (CE) (AXRX)
USOTC
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 9.3M | 10.43M | 10.51M | 7.72M | 6.37M | 4.82M | 4.43M | 3.92M |
Operating Income | 145k | 215k | 360k | 495k | 502k | 356k | 113k | 209k |
Pre Tax Income | 111k | 168k | 311k | 217k | 196k | 74k | 69k | 36k |
Net Income | 111k | 111k | 201k | 217k | 196k | 74k | 69k | 36k |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 |
EBIT | 145k | 215k | 360k | 495k | 502k | 356k | 113k | 209k |
EBITDA | 153k | 222k | 364k | 496k | 502k | 356k | 113k | 209k |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.